A Prospective, Open, Multicentre Study Analysing the Long-term Safety of MINIject Glaucoma Implants in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications
Status: Recruiting
Location: See all (9) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
The study will assess the long-term (up to 5 years) safety and performance in patients with open-angle glaucoma uncontrolled by topical hypotensive medications who had previously been implanted with a MINIject glaucoma implant.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: f
View:
• Patient who received a MINIject glaucoma implant within a prior clinical study
• Patient continues to have MINIject implanted at the point of enrolment
• Patient must provide written informed consent to participate
Locations
Other Locations
Colombia
Clinica Oftalmologica del Caribe
RECRUITING
Barranquilla
France
Center Hospotalier Universitaire Genoble Alpes
ACTIVE_NOT_RECRUITING
Grenoble
Hopital de la Croix-Rousse
ACTIVE_NOT_RECRUITING
Lyon
Germany
Uniklinik Köln
ACTIVE_NOT_RECRUITING
Cologne
Universitätsklinikum Mainz
ACTIVE_NOT_RECRUITING
Mainz
Klinikum der Universität München
RECRUITING
München
India
Maxivision Eye Hospital
RECRUITING
Hyderabad
Panama
Panama Eye Center
ACTIVE_NOT_RECRUITING
Panama City
Spain
Hospital Clínico San Carlos
ACTIVE_NOT_RECRUITING
Madrid
Contact Information
Primary
Esma Islamaj, PhD
esma.islamaj@istarmed.com
+32 10 77 12 52
Backup
Pascale Ducloux
pascale.ducloux@istarmed.com
Time Frame
Start Date: 2020-08-05
Estimated Completion Date: 2025-12
Participants
Target number of participants: 300
Related Therapeutic Areas
Sponsors
Leads: iSTAR Medical